Diffuse Optical Monitoring With Inhaled Nitric Oxide "DOMINO"

Recruiting

Phase 2 Results N/A

Summary of Purpose

This study is a non-randomized, Phase 2 clinical trial designed to measure the cerebral blood flow (CBF) response to inhaled nitric oxide in acute ischemic stroke patients and healthy subjects. The monitoring is a 35 minute session during which cerebral hemodynamics will be monitored with both diffuse correlation spectroscopy (DCS) and transcranial doppler ultrasonography (TCD) while blood pressure, heart rate,...

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 1 May 2017.

4 Apr 2017 13 Jan 2017 1 Feb 2019 1 Feb 2019 1 May 2017 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics

Interventions

Conditions

Sponsors

Trial Design

Not available

Contacts